This is certainly great news for the medical field ------
Patrys has selected a high-performing variant of Deoxymab 3E10, PAT-DX1 as the lead candidate from the program and is progressing PAT-DX1, and its nanoparticle-conjugated form PAT-DX1-NP into pre-clinical cancer models. Patrys believes that PAT-DX1 may have application across a wide range of malignancies such as gliomas, melanomas, prostate, breast, pancreatic and ovarian cancers.
If this is not fantastic I don’t know what is.
- Forums
- ASX - By Stock
- Ann: PAT-DX1 Conjugated to Nanoparticles, Targets Tumors
This is certainly great news for the medical field ------ Patrys...
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $490 | 70K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 5911085 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1726399 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 5911085 | 0.006 |
19 | 7931976 | 0.005 |
8 | 4875000 | 0.004 |
8 | 6400016 | 0.003 |
3 | 4520001 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1726399 | 6 |
0.008 | 2000000 | 2 |
0.009 | 766604 | 2 |
0.010 | 1412000 | 3 |
0.011 | 1080000 | 2 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |